Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01061801
Other study ID # 2076.00
Secondary ID
Status Completed
Phase N/A
First received February 2, 2010
Last updated February 4, 2010
Start date August 2006
Est. completion date July 2009

Study information

Verified date February 2010
Source Fred Hutchinson Cancer Research Center
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

This study seeks to test a brief psychological intervention for spousal caregivers of cancer patients (specifically, hematopoietic stem cell transplant patients), persons known to experience emotional distress.


Description:

This project focuses on spousal caregivers (CGs) of hematopoietic stem cell transplant survivors - persons known to report elevated levels of distress as compared to both norms and their patient counterparts. Specific Aims are to: (1) Determine, via experimental manipulation, whether or not CGs of hematopoietic stem cell transplant patients engage in protective buffering, a coping mechanism whereby partners shield patients from illness-related concerns or worries, (2) Examine synchrony or lack thereof, desynchrony, among subjective, expressive and biologic indicators of emotion among spousal CGs, and (3) Test the feasibility and implementation of an emotional expression (EE) exercise designed to enhance psychological and immune functioning among spousal CGs.


Recruitment information / eligibility

Status Completed
Enrollment 122
Est. completion date July 2009
Est. primary completion date July 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

- patients and partners at least 21 years of age

- patients and partners English speaking

- patients about to receive a hematopoietic stem cell transplant

- patients married or in a committed, cohabiting, heterosexual or homosexual relationship

- caregivers in a married or committed, cohabiting, heterosexual or homosexual relationship with the patient

- caregivers present at the transplant site and planning to remain so for at least one month

Exclusion Criteria:

- patient major psychiatric disorder

- caregiver presence or history of a neurologic disorder

Study Design

Allocation: Randomized, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Cancer
  • Hematopoietic Stem Cell Transplantation

Intervention

Behavioral:
Emotional expression
Caregivers are given the opportunity to express their thoughts and feelings regarding the patient's transplant and their role as caregiver

Locations

Country Name City State
United States Fred Hutchinson Cancer Research Center Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
Fred Hutchinson Cancer Research Center University of Washington

Country where clinical trial is conducted

United States, 

References & Publications (1)

Langer SL, Brown JD, Syrjala KL. Intrapersonal and interpersonal consequences of protective buffering among cancer patients and caregivers. Cancer. 2009 Sep 15;115(18 Suppl):4311-25. doi: 10.1002/cncr.24586. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Self-reported mental and physical health as measured by the Short Form-36 Health Survey baseline, 1-month follow-up, and 4-month follow-up No
Primary Marital satisfaction as measured by the Dyadic Adjustment Scale pre-transplant, baseline, 1-month follow-up, and 4-month follow-up No
Primary Self- and partner-reported protective buffering as measured by the Protective Buffering Scale pre-transplant, baseline, 1-month follow-up, and 4-month follow-up No
Secondary Emotional experience as assessed by the Positive and Negative Affect Schedule During intervention/ disclosure sessions No
Secondary Galvanic skin response (physiological indicator of emotion) During intervention/ disclosure sessions No
Secondary Emotional expression (facial expression and words uttered) During intervention/ disclosure sessions No
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients